The effects of trimetazidine on heart rate variability and signal-averaged electrocardiography in early period of acute myocardial infarction

Basit Öğe Kaydı
dc.contributor.authorUlgen, MS
dc.contributor.authorAkdemir, O
dc.contributor.authorToprak, N
dc.date.accessioned2024-06-12T11:16:42Z
dc.date.available2024-06-12T11:16:42Z
dc.date.issued2001
dc.departmentTrakya Üniversitesien_US
dc.description.abstractBackground: Acute myocardial infarction (AMI) is accompanied by electrophysiological changes in cardiovascular system as well as those in autonomic cardiac control. Heart rate variability (HRV) is depressed due to increased sympathetic activity and/or decreased parasympathetic activity following AMI. Moreover, the frequency of ventricular late potentials (VLP) is increased due to the electrophysiological changes. Based on the hypothesis that the treatments increasing HRV and decreasing the frequency of VLP can improve the prognosis of AMI, we investigated the short-term effects of trimetazidine (TMZ) on HRV and VLP in patients with AMI. Methods: The study group consisted of 64 patients (men 49, mean age 55 +/- 12 years, range 26-70) suffering from first Q-wave AMI. Thirty-one of them were treated with conventional therapy (thrombolytic therapy, aspirin, beta-blocker, heparin and intravenous nitroglycerin) plus TMZ 20 mg tid. The remaining 33 patients served as controls. Holter monitorization between 24 and 48 h, echocardiography at average day 6 (range 4-7 days) and SAECG and sub-maximal exercise at average day 7 (range 6-9 days) were performed to all patients. Results: While HRV parameters reflecting parasympathetic activity (SDSD: 43 +/- 16 ms-35 +/- 13 ms, RMSSD: 34 +/- 14 ms-27 +/- 8 ms, HF: 7.8 +/- 5 ms(2) -4.3 +/- 4 ms(2), P < 0.05) were of significantly higher levels in TMZ group, the low frequency component mainly reflecting sympathetic activity (LF: 10 6 ms(2)-10 +/- 5 ms(2), P > 0.05) was similar in both groups. In addition, LF/HF ratio showing sympatho-vagal balance was significantly decreased in TMZ group (1.5-3.0, P = 0.005). About VLP, the mean FQRS (105 +/- 8 ms-107 +/- 10 ms), LAS (28 +/- 10 ms-30 +/- 11 ms:) and RMS-40 (34 +/- 15 muV-41 +/- 12 muV) were not different in both two groups (P > 0.05). Conclusion: Our results suggest that TMZ treatment causes changes in sympatho-vagal balance in favor of vagal activity by increasing parasympathetic activity in AMI at early period; however, no effect on VLP was observed. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.en_US
dc.identifier.doi10.1016/S0167-5273(00)00441-1
dc.identifier.endpage262en_US
dc.identifier.issn0167-5273
dc.identifier.issn1874-1754
dc.identifier.issue2-3en_US
dc.identifier.pmid11182190en_US
dc.identifier.scopus2-s2.0-0035138411en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage255en_US
dc.identifier.urihttps://doi.org/10.1016/S0167-5273(00)00441-1
dc.identifier.urihttps://hdl.handle.net/20.500.14551/24413
dc.identifier.volume77en_US
dc.identifier.wosWOS:000167395000020en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Ireland Ltden_US
dc.relation.ispartofInternational Journal Of Cardiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectTrimetazidineen_US
dc.subjectHRVen_US
dc.subjectVLPen_US
dc.subjectAMIen_US
dc.subjectSudden-Deathen_US
dc.subjectArrhythmiasen_US
dc.subjectRisken_US
dc.subjectEchocardiographyen_US
dc.titleThe effects of trimetazidine on heart rate variability and signal-averaged electrocardiography in early period of acute myocardial infarctionen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu